These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. CoA-independent transacylase activity is increased in human neutrophils after treatment with tumor necrosis factor alpha. Winkler JD; Sung CM; Huang L; Chilton FH Biochim Biophys Acta; 1994 Nov; 1215(1-2):133-40. PubMed ID: 7947995 [TBL] [Abstract][Full Text] [Related]
66. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells. Chepenik KP; Wykle RL Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622 [TBL] [Abstract][Full Text] [Related]
67. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells. Hichami A; Duroudier V; Leblais V; Vernhet L; Le Goffic F; Ninio E; Legrand A Eur J Biochem; 1997 Dec; 250(2):242-8. PubMed ID: 9428670 [TBL] [Abstract][Full Text] [Related]
68. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290 [TBL] [Abstract][Full Text] [Related]
69. Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity. Tramposch KM; Chilton FH; Stanley PL; Franson RC; Havens MB; Nettleton DO; Davern LB; Darling IM; Bonney RJ J Pharmacol Exp Ther; 1994 Nov; 271(2):852-9. PubMed ID: 7965805 [TBL] [Abstract][Full Text] [Related]
70. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. Shikano M; Masuzawa Y; Yazawa K J Immunol; 1993 Apr; 150(8 Pt 1):3525-33. PubMed ID: 8468486 [TBL] [Abstract][Full Text] [Related]
71. Arachidonic acid release and platelet-activating factor formation by staurosporine in human neutrophils challenged with n-formyl peptide. Müller S; Nigam S Eur J Pharmacol; 1992 Aug; 218(2-3):251-8. PubMed ID: 1330596 [TBL] [Abstract][Full Text] [Related]
72. An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. Camussi G; Tetta C; Bussolino F; Metafora S; Peluso G; Esposito C; Porta R Eur J Biochem; 1990 Sep; 192(2):481-5. PubMed ID: 2209604 [TBL] [Abstract][Full Text] [Related]
73. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice. Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078 [TBL] [Abstract][Full Text] [Related]
74. Platelet-activating factor (PAF-acether) formation in rat basophilic leukemia cells stimulated by ionophore A23187. Hirafuji M; Nave JF Agents Actions; 1987 Oct; 22(1-2):159-64. PubMed ID: 3120519 [TBL] [Abstract][Full Text] [Related]
75. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. Ramesha CS; Pickett WC J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991 [TBL] [Abstract][Full Text] [Related]
76. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. Bauldry SA; McCall CE; Cousart SL; Bass DA J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897 [TBL] [Abstract][Full Text] [Related]
77. Role of an aprotinin-sensitive protease in protein kinase Calpha-mediated activation of cytosolic phospholipase A2 by calcium ionophore (A23187) in pulmonary endothelium. Chakraborti S; Michael JR; Chakraborti T Cell Signal; 2004 Jun; 16(6):751-62. PubMed ID: 15093616 [TBL] [Abstract][Full Text] [Related]
78. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. Tessner TG; O'Flaherty JT; Wykle RL J Biol Chem; 1989 Mar; 264(9):4794-9. PubMed ID: 2538461 [TBL] [Abstract][Full Text] [Related]
79. Vitamin E enhances the acylation of 1-O-alkyl-sn-glycero-3-phosphocholine in human endothelial cells. Tran K; D'Angelo AF; Choy PC; Chan AC Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):115-9. PubMed ID: 8129709 [TBL] [Abstract][Full Text] [Related]
80. Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase. Camussi G; Tetta C; Bussolino F; Baglioni C Eur J Biochem; 1989 Jul; 182(3):661-6. PubMed ID: 2546764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]